Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTG.L Regulatory News (WTG)

  • There is currently no data for WTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of remaining 50.1% of PT Healthcare

9 Sep 2015 07:00

RNS Number : 4959Y
Quindell PLC
09 September 2015
 



 

 

 

9 September 2015

Quindell Plc

 

("Quindell" or the "Company" or the "Group")

 

Acquisition of the remaining 50.1% of PT Healthcare Solutions Corporation

 

Quindell Plc (AIM:QPP.L) announces that it has today agreed to acquire the remaining 50.1% stake that it does not already own in PT Healthcare Solutions Corporation ("PT Health") in consideration for the issue of 9,466,666 ordinary shares of 15 pence each in the Company ("Ordinary Shares") (the "Acquisition").

 

Background

 

PT Health is a leading provider of physiotherapy and rehabilitation services in Canada, with close to 100 owned clinics and an established network of 150 additional locations which provides complete national coverage. Historically, PT Health generated business from General Practioner referrals and government funded walk-in patients. However, since becoming part of the Group, its focus has shifted to the insurance referral model which yields higher margin recurring revenues from road traffic accident injured insurance customers, and to recurring revenues from Preferred Provider Networks for large national employers under their extended healthcare benefits programs.

 

On 26 September 2013, the Company announced that it had acquired a 26% interest in PT Health in consideration for the issue of 2,103,418 Ordinary Shares. In addition, the Company announced that it had agreed a put and call option (the "Option") with the vendors of PT Health, enabling Quindell to acquire the remaining 74% of PT Health subject to certain conditions.

 

Following a variation of the Option, the Company announced on 31 March 2014 that it had acquired a further 23.9% stake in PT Health in consideration for the issue of 6,666,666 Ordinary Shares.

 

For the period from 1 April 2014 to 31 December 2014, PT Health reported revenue of CDN$38.7 million (£19.1 million), a net loss of CDN$20.7 million (£10.2 million), a loss adjusted for non-recurring items and before tax of CDN$2.8 million (£1.4 million) and net assets of CDN$41.8 million (£20.6 million).

 

Transaction

 

Pursuant to the Option, the Group is to acquire the remaining 50.1% of PT Health, the terms of which have now been agreed and are detailed in an arrangement agreement (the "Arrangement Agreement"). Under the terms of the Arrangement Agreement, Quindell will issue 9,466,666 Ordinary Shares in consideration for the Acquisition.

 

The Acquisition is to be effected pursuant to an arrangement under the Canada Business Corporations Act. Completion of the Acquisition is subject to customary closing conditions, including court approval of the arrangement, approval of two-thirds of the votes cast by the holders of PT Health common shares at a special meeting of shareholders to be called to consider the arrangement, and applicable regulatory approval. Following a review and analysis of the proposed transaction, the PT Health board has unanimously approved the transaction and recommends that PT Health's common shareholders vote in favour of the arrangement. In addition, all of the directors and executive officers of PT Health have signed agreements to vote their shares in favour of the transaction. The Acquisition is scheduled to close in mid-October 2015.

 

PT Health is deemed to be a related party of the Company for the purposes of the AIM Rules, and is a party to the Arrangement Agreement. The directors of the Company consider, having consulted with Peel Hunt LLP in its capacity as the Company's nominated adviser, that the terms of the transaction are fair and reasonable insofar as its shareholders are concerned.

 

PT Health is currently treated as a subsidiary of the Group and consolidated into the Group's accounts. Post completion of the Acquisition, PT Health will become a wholly owned subsidiary of Quindell.

 

Completion of the Acquisition is expected to take place in mid-October 2015 and application will be made for the 9,466,666 Ordinary Shares to be admitted to AIM in due course.

 

For further information:

 

Quindell Plc

Tel: 01489 864 200

Indro Mukerjee, Chief Executive Officer

Stephen Joseph, Head of Investor Relations

Tulchan Communications

Tel: 020 7353 4200

Victoria Huxster

 

Peel Hunt LLP, Nominated Adviser and broker

 

Tel: 020 74188900

Dan Webster

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEASNNESFSEEF
Date   Source Headline
7th Jul 20217:00 amRNSCancellation - Watchstone Group PLC
6th Jul 20216:00 pmRNSWatchstone Group
5th Jul 20213:58 pmRNSForm 8.3 - Watchstone Group Plc
5th Jul 20212:05 pmRNSHolding(s) in Company
2nd Jul 20215:56 pmRNSHolding(s) in Company
2nd Jul 20215:09 pmRNSReplacement Form 8 (DD) - Watchstone Group plc
2nd Jul 20214:27 pmRNSHolding(s) in Company
2nd Jul 20212:03 pmRNSForm 8.3 - Watchstone Group Plc
2nd Jul 20211:45 pmGNWMan Group PLC : Form 8.3 - Watchstone Group plc
2nd Jul 202112:39 pmRNSForm 8 (DD) - Watchstone Group plc
2nd Jul 20217:05 amRNSForm 8 (OPD) Watchstone Group plc
1st Jul 20215:08 pmRNSRule 2.9 Announcement
1st Jul 20213:42 pmRNSOffer Update
1st Jul 20212:29 pmRNSForm 8 (DD) - Watchstone Group plc
1st Jul 20212:18 pmRNSOffer for Watchstone Group plc
29th Jun 202111:13 amRNSResult of AGM
24th May 20217:00 amRNSPublication of Accounts, Circular & Notice of AGM
7th May 202111:14 amRNSHolding(s) in Company
6th May 20217:00 amRNSFinal Results
6th May 20217:00 amRNSProposed Cancellation of Admission to AIM
4th May 20217:30 amRNSSuspension - Watchstone Group PLC
23rd Apr 20217:00 amRNSIntention to apply for admission to the AQSE
4th Feb 20214:35 pmRNSPrice Monitoring Extension
29th Dec 20208:36 amRNSHolding(s) in Company
23rd Dec 202011:30 amRNSHolding(s) in Company
18th Dec 20208:22 amRNSHolding(s) in Company
2nd Nov 20207:00 amRNSDisposal
28th Oct 20209:38 amRNSResult of Meeting
12th Oct 20203:53 pmRNSHolding(s) in Company
8th Oct 20207:00 amRNSHolding(s) in Company
8th Oct 20207:00 amRNSProposed disposal of the Ingenie Business
29th Sep 20207:00 amRNSHalf-year Report
27th Aug 20207:00 amRNSHolding(s) in Company
7th Aug 202011:22 amRNSClaim against PricewaterhouseCoopers LLP
21st Jul 202010:46 amRNSSecond Share Premium Reduction & Return of Cash
24th Jun 20201:30 pmRNSResult of AGM
11th Jun 20205:52 pmRNSHolding(s) in Company
9th Jun 202011:00 amRNSFirst Share Premium Reduction & Return of Cash
29th May 20207:00 amRNSFurther Return of Cash, Accounts & Notice of AGM
28th May 20203:36 pmRNSHolding(s) in Company
15th May 202010:25 amRNSDirector/PDMR Shareholding
14th May 20201:06 pmRNSDirector/PDMR Shareholding
13th May 20207:00 amRNSFinal Results
28th Apr 20207:00 amRNSRegulatory update – No prosecution of the Company
27th Apr 202010:34 amRNSResult of Meeting
16th Apr 20204:47 pmRNSHolding(s) in Company
16th Apr 20201:39 pmRNSHolding(s) in Company
15th Apr 20209:07 amRNSHolding(s) in Company
9th Apr 20207:00 amRNSProposed Share Premium Reduction & Return of Cash
25th Mar 20209:30 amRNSUpdate

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.